Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Evaluation of the Effectiveness of the Pecha Kucha-Supported Microteaching Method in Nursing Process Education

30. juni 2026 oppdatert av: Sevim Uzuncan, Istanbul University - Cerrahpasa
This randomized controlled study aims to evaluate the effectiveness of the Pecha Kucha-supported microteaching method in nursing process education among first-year nursing students. Participants will be randomly assigned to either an intervention group receiving Pecha Kucha-supported microteaching or a control group receiving traditional instruction. The effects of the intervention on nursing process competencies and learning motivation will be evaluated.

Studieoversikt

Detaljert beskrivelse

The nursing process is a systematic and scientific method that guides nursing care. Developing nursing students' competencies in the nursing process is essential for providing high-quality patient care. Innovative teaching methods may enhance students' learning experiences and improve educational outcomes.

This randomized controlled study aims to evaluate the effectiveness of the Pecha Kucha-supported microteaching method in nursing process education among first-year nursing students. Participants will be randomly assigned to an intervention group or a control group. The intervention group will receive Pecha Kucha-supported microteaching, while the control group will receive traditional instruction. Following the educational intervention, students will prepare nursing care plans during their clinical practice.

Outcomes will be evaluated using a Nursing Process Knowledge Form, the Instructional Materials Motivation Survey, and the Quality of Nursing Diagnoses, Interventions and Outcomes (Q-DIO) instrument. The study will assess the effects of the intervention on nursing process competencies and learning motivation.

Studietype

Intervensjonell

Registrering (Faktiske)

100

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiesteder

    • Avcılar
      • Istanbul, Avcılar, Tyrkia (Türkiye), 34310
        • Istanbul University-Cerrahpasa, Florence Nightingale Faculty of Nursing

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

  • Voksen
  • Eldre voksen

Tar imot friske frivillige

Ja

Beskrivelse

Inclusion Criteria:

  • First-year nursing students
  • Successfully completed prerequisite nursing courses
  • Grade point average (GPA) of 1.80 or higher
  • Voluntary agreement to participate in the study
  • Providing written informed consent

Exclusion Criteria:

  • Students repeating the course
  • Graduates of Vocational School of Health Services programs
  • Withdrawal from the study at any stage
  • Failure to complete study assessments or data collection forms

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Helsetjenesteforskning
  • Tildeling: Randomisert
  • Intervensjonsmodell: Parallell tildeling
  • Masking: Ingen (Open Label)

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: Experimental Group
Nursing students who received a brief refresher lecture on the nursing process and participated in Pecha Kucha-supported microteaching activities based on case scenarios. Students subsequently prepared individual nursing care plans during clinical practice.
Nursing students first received a brief refresher lecture on the nursing process. The experimental group, consisting of 50 students, was then divided into five groups of 10 students each. Each group was assigned a case scenario and a nursing diagnosis. Students were asked to prepare a presentation using the Pecha Kucha-supported microteaching method based on the assigned case and nursing diagnosis. One student from each group delivered the presentation on behalf of the group. Feedback sessions were conducted following the presentations. Subsequently, students prepared individual nursing care plans for patients cared for during clinical practice.
Aktiv komparator: Control Group
Nursing students who received a brief refresher lecture on the nursing process and prepared group nursing care plans based on case scenarios. Students subsequently prepared individual nursing care plans during clinical practice.
Nursing students first received a brief refresher lecture on the nursing process. The control group, consisting of 50 students, was then divided into five groups of 10 students each. Each group was assigned a case scenario and a nursing diagnosis. Students were asked to collaboratively prepare a nursing care plan based on the assigned case and nursing diagnosis. Following this activity, students prepared individual nursing care plans for patients cared for during clinical practice.

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Quality of Nursing Diagnoses, Interventions and Outcomes
Tidsramme: After completion of the educational intervention (approximately 4 weeks after baseline) and at the end of the clinical practice period (approximately 12 weeks after baseline).
The quality of nursing care plans will be evaluated using the Quality of Nursing Diagnoses, Interventions and Outcomes (Q-DIO) instrument. The Q-DIO is a 29-item instrument designed to assess the quality of nursing documentation, including nursing diagnoses, nursing interventions, and nursing-sensitive patient outcomes. The instrument consists of four domains: Nursing Diagnoses as Process, Nursing Diagnoses as Outcomes, Nursing Interventions, and Nursing-Sensitive Patient Outcomes. Higher scores indicate higher quality and more comprehensive documentation of nursing diagnoses, interventions, and patient outcomes in nursing care plans.
After completion of the educational intervention (approximately 4 weeks after baseline) and at the end of the clinical practice period (approximately 12 weeks after baseline).

Sekundære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Nursing Process Knowledge Level Assessment Form
Tidsramme: At baseline and at the end of the clinical practice period (approximately 12 weeks after baseline).
Students' knowledge of the nursing process will be evaluated using the Nursing Process Knowledge Level Assessment Form developed by the researcher. The form consists of 25 multiple-choice questions. The questions assess students' knowledge related to the nursing process, including assessment, nursing diagnosis, planning, implementation, and evaluation stages. The form was reviewed by three experts, and necessary revisions were made in line with expert feedback. Higher scores indicate a higher level of knowledge regarding the nursing process.
At baseline and at the end of the clinical practice period (approximately 12 weeks after baseline).
Instructional Materials Motivation Survey
Tidsramme: At the end of the clinical practice period (approximately 12 weeks after baseline).
Students' learning motivation will be evaluated using the Instructional Materials Motivation Survey (IMMS), which is based on Keller's ARCS (Attention, Relevance, Confidence, Satisfaction) motivation model. The survey consists of 24 items and two subscales: Attention-Relevance and Confidence-Satisfaction. The Attention-Relevance subscale evaluates students' interest in and perceived relevance of the instructional content, whereas the Confidence-Satisfaction subscale assesses students' confidence and satisfaction with the learning experience. Responses are rated on a 5-point Likert scale ranging from 1 (strongly disagree) to 5 (strongly agree). Total scores range from 24 to 120, with higher scores indicating higher levels of learning motivation.
At the end of the clinical practice period (approximately 12 weeks after baseline).

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Etterforskere

  • Studiestol: Funda Büyükyılmaz, Professor, Istanbul University-Cerrahpasa, Florence Nightingale Faculty of Nursing

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

9. april 2026

Primær fullføring (Antatt)

30. juni 2026

Studiet fullført (Antatt)

30. juni 2026

Datoer for studieregistrering

Først innsendt

23. juni 2026

Først innsendt som oppfylte QC-kriteriene

30. juni 2026

Først lagt ut (Faktiske)

1. juli 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

1. juli 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

30. juni 2026

Sist bekreftet

1. juni 2026

Mer informasjon

Begreper knyttet til denne studien

Andre studie-ID-numre

  • 2025-749

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

NEI

IPD-planbeskrivelse

Individual participant data will not be shared because the study involves educational data collected from nursing students, and participant confidentiality and privacy will be protected in accordance with ethical approval and institutional regulations.

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere